May 4, 2020 / 12:31 PM / a month ago

BRIEF-Kala Pharmaceuticals Resubmits New Drug Application For EYSUVIS

May 4 (Reuters) - Kala Pharmaceuticals Inc:

* KALA PHARMACEUTICALS RESUBMITS NEW DRUG APPLICATION FOR EYSUVIS™ FOR DRY EYE DISEASE

* KALA PHARMACEUTICALS INC - PREPARING FOR A POTENTIAL U.S. APPROVAL AND LAUNCH BY END OF 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below